Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
P01AB07	SECNOL	G	Secnidazole anhydre - 2g	2g	Granules	842,589 L.L
P01AB07	SECNOL	G	Secnidazole - 2g	2g	Granules	842,589 L.L
R03DC03	SINGULAIR PAEDIATRIC	B	Montelukast (sodium) - 4mg	4mg	Granules	1,248,430 L.L
A07EC02	SALOFALK	B	Mesalazine - 1000mg	1000mg	Granules, gastro-resistant, prolonged release	3,874,298 L.L
A07EC02	SALOFALK	B	Mesalazine - 1.5g	1.5g	Granules, gastro-resistant, prolonged release	6,150,767 L.L
A07EC02	SALOFALK	B	Mesalazine - 3g	3g	Granules, gastro-resistant, prolonged release	11,256,652 L.L
N01AB07	SUPRANE (DESFLURANE, USP)	B	Desflurane -		Inhalation	9,371,654 L.L
N01AB08	SEVOFLURANE	B	Sevoflurane -		Inhalation	12,327,290 L.L
R03AK06	SERETIDE DISKUS 100	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 100mcg/inhalation		Inhalation powder	2,276,469 L.L
R03AK06	SERETIDE DISKUS 250	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation powder	2,830,132 L.L
R03AK06	SERETIDE DISKUS 500	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation		Inhalation powder	3,199,689 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 4.5mcg/Inhalation, Budesonide - 160mcg/Inhalation		Inhalation powder	3,378,420 L.L
R03AK07	SYMBICORT TURBUHALER	B	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Inhalation powder	1,689,210 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 9mcg/Inhalation, Budesonide - 320mcg/Inhalation		Inhalation powder	3,378,420 L.L
R03AL06	SPIOLTO RESPIMAT	B	Olodaterol HCl - 2.5mcg/puff, Tiotropium bromide monohydrate - 2.5mcg/puff		Inhalation solution	5,087,788 L.L
R03AK06	SEROFLO 500	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation		Inhalation suspension	2,031,890 L.L
R03AK06	SEROFLO-S 125	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 125mcg/inhalation		Inhalation suspension	1,212,146 L.L
R03AK06	SEROFLO 250	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,580,359 L.L
R03AK06	SEROFLO-S 250	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,725,494 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	235,593,517 L.L
L01FG01	STIVANT	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	27,359,527 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	L.L
L01FG01	STIVANT	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	14,719,570 L.L
L04AD01	SANDIMMUN	B	Ciclosporin - 50mg/ml	250mg/5ml	Injectable concentrated solution	6,992,013 L.L
L03AX03	SII-ONCO-BCG	G	Bacillus Calmette- Guerin Strain - 40mg/ml (1-8x10⁸CFU)	40mg/ml	Injectable dry powder	6,987,981 L.L
B05BA02	SMOFLIPID	G	Soya oil - 6%, Olive oil - 5%, Fish oil - 3%, Medium chain triglycerides - 6%	20%	Injectable emulsion	1,424,473 L.L
B05BA10	SMOFKABIVEN	G	Glucose monohydrate - 462mg, Soya-bean oil, refined - 60mg, Triglycerides, Medium Chain - 60mg, Olive oil, refined - 50mg, Fish oil, rich in omega-3-acids - 30mg, Alanine - 14mg, Arginine - 12mg, Proline - 11.2mg, Glycine - 11mg, Lysine acetate - 9.3mg, Leucine - 7.4mg, Serine - 6.5mg, Valine - 6.2mg, Sodium acetate, 3H2O - 5.62mg, Phenylalanine - 5.1mg, Isoleucine - 5mg, Potassium chloride - 4.48mg, Threonine - 4.4mg, Methionine - 4.3mg, Sodium glycerophosphate, anhydrous - 4.18mg, Histidine - 3mg, Magnesium sulfate, 7H2O - 2.47mg, Tryptophan - 2mg, Taurine - 1mg, Calcium chloride 2H2O - 0.74mg, Tyrosine - 0.40mg, Zinc sulfate heptahydrate - 23mcg		Injectable emulsion	3,835,326 L.L
B05BA10	SMOFKABIVEN PERIPHERAL	G	Glucose monohydrate - 143mg, Soya-bean oil, refined - 60mg, Triglycerides, Medium Chain - 60mg, Olive oil, refined - 50mg, Fish oil, rich in omega-3-acids - 30mg, Alanine - 14mg, Arginine - 12mg, Proline - 11.2mg, Glycine - 11mg, Lysine acetate - 9.3mg, Leucine - 7.4mg, Serine - 6.5mg, Valine - 6.2mg, Sodium acetate, 3H2O - 5.62mg, Phenylalanine - 5.1mg, Isoleucine - 5mg, Potassium chloride - 4.48mg, Threonine - 4.4mg, Methionine - 4.3mg, Sodium glycerophosphate, anhydrous - 4.18mg, Histidine - 3mg, Magnesium sulfate, 7H2O - 2.47mg, Tryptophan - 2mg, Taurine - 1mg, Calcium chloride 2H2O - 0.74mg, Tyrosine - 0.40mg, Zinc sulfate heptahydrate - 23mcg		Injectable emulsion	4,571,752 L.L
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
H02AB09	SOLU CORTEF ACT-O-VIAL	B	Hydrocortisone (sodium succinate) - 250mg	250mg	Injectable lyophilised powder for solution+diluent	421,967 L.L

...